IP Library Granted Patent US 8,734,781
Granted Patent B2
US 8,734,781 · App. 13/765,329 · Granted May 27, 2014

Method of preventing early

Inventors: Ricarda Deitmer (Gau-Algesheim, DE); Knut Elbers (Mittelbiberach, DE)
Assignee: Boehringer Ingelheim Vetmedica, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,734,781
App. No.
13/765,329
Granted
May 27, 2014
Kind
B2
Abstract

The present invention relates inter alia to the use of a combination of a vaccine against Lawsonia intracellularis and an anti- Lawsonia antibiotic for the prevention or reduction of early, preferably fulminant Lawsonia intracellularis infections. The present invention relates particularly to the use of a live Lawsonia intracellularis vaccine in conjunction with an antibiotic that is effective against Lawsonia intracellularis , for the avoidance or reduction of early Lawsonia intracellularis infections in animals.

Claims (15)

1. A method of reducing early Lawsonia intracellularis infection in piglets as compared to unvaccinated piglets or piglets treated only with an anti- Lawsonia antibiotic that is effective against Lawsonia intracellularis , comprising administering a live attenuated Lawsonia intracellularis vaccine and administering the anti- Lawsonia antibiotic, wherein said live attenuated Lawsonia intracellularis vaccine is administered at about four weeks of life of said piglets and the anti- Lawsonia antibiotic is administered over a period of 12 to 21 days starting at day 3, 4, 5, 6 or 7 after the administration of said live attenuated Lawsonia intracellularis vaccine.

2. The method according to claim 1 , wherein said early infection is a fulminant infection.

3. The method according to claim 1 , wherein said live attenuated Lawsonia intracellularis vaccine is administered at three weeks of life of said piglets.

4. The method according to claim 2 , wherein said anti- Lawsonia antibiotic is administered at least until reliable immunity against said early fulminant Lawsonia intracellularis infection is detected.

5. The method according to claim 4 , wherein the reliable immunity is determined by the detection of Lawsonia intracellularis -specific antibodies in the piglets administered with the live attenuated Lawsonia intracellularis vaccine and the anti- Lawsonia antibiotic.

6. The method according to claim 1 , further comprising additionally administering said anti- Lawsonia antibiotic, wherein the anti- Lawsonia antibiotic is administered from 1 to 3 days before the administration of said live attenuated Lawsonia intracellularis vaccine.

7. The method according to claim 1 , wherein said anti- Lawsonia antibiotic is acetylisovaleryltylosin, lincospectin, tiamulin, tulathromycin (draxxin), tylosin, valnemulin, or a combination thereof.

8. The method according to claim 7 , wherein tylosin is administered in an amount of 10 to 50 mg/kg of body weight of the piglets.

9. The method according to claim 1 , wherein the reduction of the early Lawsonia intracellularis infection in the piglets results in an improved weight gain in the piglets in the first fifty days of life after the vaccination as compared with the unvaccinated piglets or the piglets treated only with the antibiotic.

10. The method according to claim 9 , wherein said improved weight gain is at least 1 kg.

11. A method of reducing early Lawsonia intracellularis infection in piglets as compared to unvaccinated piglets or piglets treated only with tylosin antibiotic, comprising administering a live attenuated Lawsonia intracellularis vaccine and administering the tylosin antibiotic, wherein said live attenuated Lawsonia intracellularis vaccine is administered at about four weeks of life of said piglets and the tylosin antibiotic is administered over a period of 12 to 21 days starting at day 3, 4, 5, 6 or 7 after the administration of said live attenuated Lawsonia intracellularis vaccine.

12. The method according to claim 11 , wherein said early infection is a fulminant infection.

13. The method according to claim 11 , wherein said live attenuated Lawsonia intracellularis vaccine is administered at three weeks of life of said piglets.

14. The method according to claim 12 , wherein said tylosin antibiotic is administered at least until reliable immunity against said early fulminant Lawsonia intracellularis infection is detected.

15. The method according to claim 11 , wherein said tylosin antibiotic is administered in an amount of 10 to 50 mg/kg of body weight of the piglets.

Assignments (2)
MERGER AND CHANGE OF NAME Recorded Jul 24, 2020
From: BOEHRINGER INGELHEIM VETMEDICA, INC.; BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
To: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
Reel/Frame 053310/0361 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 22, 2020
From: DEITMER, RICARDA; ELBERS, KNUT
To: BOEHRINGER INGELHEIM VETMEDICA, INC.
Reel/Frame 053281/0798 →
Priority Claims (1)
EP 07116528 · Sep 17, 2007 · regional
Continuity (2)
Division 12678361
Related Publication 20130156811A1 · Jun 20, 2013